In vehicle-treated cells, utilizing two different anti-human PR primary antibodies that recognize both PR isoforms with varied efficacy, we detected PR-A and PR-B only in MCF-7 breast cancer cells. This evidence concerns the gene S100A6 and breast carcinoma.